{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-099067","form_type":"8-K","ticker":"INO","cik":"0001055726","company_name":"INOVIO PHARMACEUTICALS, INC.","filed_at":"2024-04-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.068044+00:00","generated_at":"2026-06-03T21:28:48.592369+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Inovio priced ~$36M underwritten offering of common stock and pre-funded warrants","bullets":["Priced 2,536,258 shares at $7.693/share and pre-funded warrants for 2,135,477 shares at $7.692/warrant.","Gross proceeds ~$36M; net proceeds ~$33.2M after underwriting discounts and expenses.","Offering led by Deep Track Capital; closes on or about April 18, 2024.","Oppenheimer & Co. and Citizens JMP Securities acting as joint book-running managers."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-099067","json":"https://secwatch.observer/filing/0001193125-24-099067.json","markdown":"https://secwatch.observer/filing/0001193125-24-099067.md","text":"https://secwatch.observer/filing/0001193125-24-099067.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1055726/000119312524099067/0001193125-24-099067-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1055726/000119312524099067/d817715d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T21:28:48.592369+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"05d4ea860b0b0e686b5a08518ced6515aac2bbc0","claim":"INOVIO PHARMACEUTICALS, INC. entered into Underwriting Agreement with Oppenheimer & Co. Inc. and Citizens JMP Securities, LLC, as representatives of the several underwriters named therein valued at approximately $33.2 million (effective 2024-04-15).","evidence_excerpt":"On April 15, 2024, Inovio Pharmaceuticals, Inc. (the “ Company ”) entered into an underwriting agreement (the “ Underwriting Agreement ”) with Oppenheimer & Co. Inc. and Citizens JMP Securities, LLC, as representatives of the several underwriters named therein (collectively, the “ Underwriters ”), relating to the issuance and sale by the Company in an underwritten registered direct offering (the “ Offering ”) of 2,536,258 shares (the “ Shares ”) of the Company’s common stock, par value $0.001 per share (the “ Common Stock ”), at a price of $7.693 per share and pre-funded warrants to purchase up to 2,135,477 shares of Common Stock (the “ Pre-Funded Warrants ”) at a price of $7.692 per Pre-Funded Warrant, which represents the per share price for the Shares less the $0.001 per share exercise price for each Pre-Funded Warrant.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1055726/000119312524099067/0001193125-24-099067-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"Oppenheimer & Co. Inc. and Citizens JMP Securities, LLC, as representatives of the several underwriters named therein"},{"label":"Value","value":"approximately $33.2 million"},{"label":"Effective","value":"2024-04-15"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}